Yvonne Smith Selected Research

Breast Neoplasms (Breast Cancer)

1/2019

Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yvonne Smith Research Topics

Disease

1	Type 2 Diabetes Mellitus (MODY) 09/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2009

Drug/Important Bio-Agent (IBA)

1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	neratinibIBA 01/2019
1	Fumigant 93 (D-D)IBA 10/2009

Therapy/Procedure

1	Glycemic Control 09/2020
1	Therapeutics 01/2019
1	Neoadjuvant Therapy 01/2019